Search - tctmd.com

Displaying 781 - 800 of 1066

Sort: Relevancy | Date

Presentation TCT 2017

IVUS-Guided vs OCT-Guided PCI: Advantages and Disadvantages

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Case #4: Delayed Partial Obstruction of the RCA After TAVR

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Jung-Cheng Hsu

October 29, 2017

Presentation TCT 2017

Case #4: STEMI With Massive Thrombus

Presenter: Jose L. Leiva-Pons

October 29, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Case Presentation 4: Carotid Artery Stenting

Presenter: Sergey A. Abugov, Juan F. Granada, Narek Zakaryan

October 29, 2017

Presentation TCT 2017

Complex and High-Risk PCI: Who Should Perform These Procedures?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Qi Zhang

October 29, 2017

Presentation TCT 2017

Heavy Coronary Calcification

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Amr Mahmoud Zaki

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle

October 29, 2017

Presentation TCT 2017

How Would I Treat This Case?

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Toshiya Muramatsu

October 29, 2017

Presentation TCT 2017

Troubleshooting During Left Atrial Appendage Closure

Presenter: Helene Eltchaninoff, Afzalur Rahman, Rabin dra Nath Chakraborty

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Editorial Comment

Presenter: Juan F. Granada, Jeffrey W. Moses

October 29, 2017

Presentation TCT 2017

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Daniel H. Berrocal

October 29, 2017

Presentation TCT 2017

Case #3: Infected Coronary Aneurysm After PCI for STEMI

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Wei-Chun Huang

October 29, 2017

Presentation TCT 2017

Case #3: STEMI Due to a Critical Left Main Stenosis

Presenter: Jose L. Leiva-Pons, Jorge Antonio Mayol Almera

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Case Presentation 3: Multivessel PCI

Presenter: Juan F. Granada, Roman Tarasov

October 29, 2017

Presentation TCT 2017

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

Presenter: Antonio Colombo, Azeem Latib, Jason H. Rogers

October 29, 2017

Presentation TCT 2017

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Hany Ragy

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

Advertisement

IVUS-Guided vs OCT-Guided PCI: Advantages and Disadvantages

Case #4: Delayed Partial Obstruction of the RCA After TAVR

Case #4: STEMI With Massive Thrombus

Next Generation BRS Platforms

Case Presentation 4: Carotid Artery Stenting

Complex and High-Risk PCI: Who Should Perform These Procedures?

Heavy Coronary Calcification

Bioresorbable Scaffolds and Outcomes 2017

How Would I Treat This Case?

Troubleshooting During Left Atrial Appendage Closure

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Editorial Comment

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Case #3: Infected Coronary Aneurysm After PCI for STEMI

Case #3: STEMI Due to a Critical Left Main Stenosis

Lessons from the ABSORB Clinical Program for the Future

Case Presentation 3: Multivessel PCI

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content